ライフサイエンスコーパス: stress incontinence

1 the Burch colposuspension--among women with stress incontinence.

2 cacious and an important therapy in managing stress incontinence.

3 le of these procedures in difficult cases of stress incontinence.

4 ce in women without preoperative symptoms of stress incontinence.

5 overactivity or sling procedures for female stress incontinence.

6 ge incontinence should be distinguished from stress incontinence.

7 secured its place in the treatment of female stress incontinence.

8 tinence but was not predictive in a study of stress incontinence.

9 nce continued incontinence despite "cure" of stress incontinence.

10 ed to quantify urine leakage associated with stress incontinence.

11 prehensive behavioral program for women with stress incontinence.

12 on (PFES) has been shown to be effective for stress incontinence.

13 nsobturator midurethral slings in women with stress incontinence.

14 neuromodulation, and surgical procedures for stress incontinence.

15 eficiency prior to surgical intervention for stress incontinence?

16 inence than those in the Burch group who had stress incontinence (24.5 percent vs. 6.1 percent, P<0.0

17 s. 38%, P=0.01) and the category specific to stress incontinence (66% vs. 49%, P<0.001).

18 acceptable accuracy for classifying urge and stress incontinence and may be appropriate for use in pr

19 Women who did not report symptoms of stress incontinence and who chose to undergo sacrocolpop

20 er trial involving women without symptoms of stress incontinence and with anterior prolapse (of stage

21 in a higher rate of successful treatment of stress incontinence but also greater morbidity than the

22 s are increasingly used for the treatment of stress incontinence, but there are limited data comparin

23 ency of all incontinence episodes (P<0.001), stress-incontinence episodes (P=0.009), and urge-inconti

24 p had a greater decrease in the frequency of stress-incontinence episodes (P=0.02), but not of urge-i

25 As surgical treatment of stress incontinence evolves, thorough understanding of s

26 Surgical management of female stress incontinence has progressed rapidly over the past

27 Reported cure rates for stress incontinence immediately after a course of perine

28 er of surgical procedures to correct urinary stress incontinence in the female have been described.

29 ecause of a significantly lower frequency of stress incontinence in the group that underwent the Burc

30 fective and safe method for treating urinary stress incontinence in women, and have delivered improve

31 ruction is a consequence of surgery to treat stress incontinence in women.

32 rventions are effective in the management of stress incontinence, including open retropubic colposusp

33 f obstructed, overactive bladder with hidden stress incontinence increases with degree of POP, and al

34 e contemporary surgical treatment of urinary stress incontinence is by suburethral sling; so this rev

35 There is no FDA-approved drug for stress incontinence or overflow incontinence.

36 controls met one or more of the criteria for stress incontinence (P<0.001).

37 radic reports of unexpectedly high recurrent stress incontinence rates with some biological slings ha

38 e of urethral bulking and oral medicines for stress incontinence remains low because of inconsistent

39 omen with urethral hypermobility and genuine stress incontinence seems clear.

40 hageal reflux disease, hypertension, urinary stress incontinence, sleep apnea, obesity hypoventilatio

41 ndition, and success in terms of measures of stress incontinence specifically, which required only th

42 Stress incontinence surgery, the midurethral sling, is a

43 The primary outcomes included measures of stress incontinence (symptoms, stress testing, or treatm

44 more likely to report bothersome symptoms of stress incontinence than those in the Burch group who ha

45 For classification of stress incontinence, the sensitivity was 0.86 (CI, 0.79

46 us injectable materials for the treatment of stress incontinence, there is no clear data to establish

47 The anatomic structures that prevent stress incontinence, urinary incontinence during elevati

48 In women without stress incontinence who are undergoing abdominal sacroco

49 bjectively assessed success of treatment for stress incontinence with the retropubic and transobturat

50 nificantly reduced postoperative symptoms of stress incontinence without increasing other lower urina

51 cedures are available for women with urinary stress incontinence, yet few randomized clinical trials